'Overwhelming' bleeding reduction with abelacimab versus rivaroxaban in AF leads to early halting of trial Medha Baranwal20 Sept 2023 11:30 AM ISTUSA: Abelacimab, a novel factor XI/XIa inhibitor being studied in the AZALEA-TIMI 71 trial, was shown to lower a composite of major and clinically...
Metronidazole reasonable treatment option for patients with symptomatic oral lichen planus Medha Baranwal20 Sept 2023 9:45 AM ISTUSA: A recent study published in Clinical and Experimental Dermatology has shown metronidazole to be a reasonable option for patients with symptomatic...
Evinacumab effective and well tolerated for LDL cholesterol lowering in refractory hypercholesterolemia patients: JAMA Medha Baranwal19 Sept 2023 11:30 AM ISTUSA: A recent study published in JAMA Cardiology has demonstrated the potential utility of evinacumab as an effective and generally well-tolerated...
Gout flares significantly associated with VTE in subsequent 90 days Medha Baranwal19 Sept 2023 11:15 AM ISTUK: A recent study published in Arthritis & Rheumatology has found a transient increase in the rate of venous thromboembolism (VTE) within 30 days...
Stress hyperglycemia ratio predicts post-MI new-onset AF in non-diabetic individuals Medha Baranwal19 Sept 2023 10:45 AM ISTChina: A recent study has revealed that diabetes patients having both high-stress hyperglycemia ratio (SHR) and new-onset atrial fibrillation (NOAF)...
Elevated marker of IgE-mediated mast cell activation predicts omalizumab response in chronic spontaneous urticaria Medha Baranwal19 Sept 2023 10:15 AM ISTOmalizumab is an anti-IgE monoclonal antibody that is suggested to be an effective treatment in chronic spontaneous urticaria.
Eye-tracking-based measurement may aid in autism diagnoses in young children: JAMA Medha Baranwal19 Sept 2023 9:30 AM ISTUSA: Eye-tracking-based measurement of social visual engagement was predictive of autism diagnoses by clinical experts in young children aged 16- to...
Elevated calcium scores in adults without ASCVD linked to increased CV risk: JACC Medha Baranwal19 Sept 2023 9:15 AM ISTUSA: A recent study published in JACC Cardiovascular Imaging by Budoff MJ and colleagues aimed to determine the appropriate threshold for recommending...
Change in percent atheroma volume could be surrogate marker for adverse CV events: JAMA Medha Baranwal16 Sept 2023 11:45 AM ISTCanada: In a comprehensive meta-analysis published in JAMA Cardiology by Iulia Iatan and colleagues related to lipid-lowering therapy trials, a 1%...
High-Dose Intravenous Immunoglobulins Improve Outcomes in Autoimmune Bullous Diseases: Medha Baranwal16 Sept 2023 4:00 AM ISTGermany: A recent study published in the Journal Of The European Academy Of Dermatology & Venereology by M. Bertlich and colleagues suggests that...
ESC/EACTS recommends adjusting PCI for left main CAD in low surgical risk patients Medha Baranwal15 Sept 2023 8:00 PM ISTItaly: A European task force comprised of cardiologists, interventionalists, and cardiac surgeons from the European Society of Cardiology (ESC) and...
Presence of FFR–negative high-risk non-culprit plaque tied to worse clinical outcomes in patients with MI: JAMA Medha Baranwal15 Sept 2023 8:00 PM ISTNetherlands: A recent study published in JAMA Cardiology showed an association between the presence of a fractional flow reserve (FFR)–negative...
